NHS Logo
Bedfordshire and Luton Joint Formulary
Bedfordshire Hospitals NHS Foundation Trust
Bedfordshire, Luton and Milton Keynes ICB
Formulary items found
Status Description Section
GREENDapagliflozin Forxiga®
(For Heart Failure) 		Cardiovascular system, Heart Failure, 02.05.05
GREENDapagliflozin
(For patients with Type 2 diabetes) 		Endocrine system, SGLT2 inhibitors, 06.01.02.03
 Dapagliflozin
(For Chronic kidney disease) 		Obstetrics, Gynaecology, and urinary-tract disorders, Other preparations for urinary disorders, 07.04.03
GREENErtugliflozin Steglatro®
(For patients with Type 2 diabetes) 		Endocrine system, SGLT2 inhibitors, 06.01.02.03
Non Formulary items found
Status Description Section
DNPDapagliflozin
(For Type 1 diabetes) 		Endocrine system, SGLT2 inhibitors, 06.01.02.03
Searchiing the National BNF we found these items - Click button under Local to search local formulary or BNF to view on online BNF.
Local BNF Section
Dapagliflozin Dapagliflozin Cardiovascular System, Blood Glucose Lowering Drugs, Sodium Glucose Co-Transporter 2 Inhibitors
Heart Failure
Dapagliflozin Dapagliflozin Endocrine System, Blood Glucose Lowering Drugs, Sodium Glucose Co-Transporter 2 Inhibitors
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Dapagliflozin Dapagliflozin Genito-Urinary System, Blood Glucose Lowering Drugs, Sodium Glucose Co-Transporter 2 Inhibitors
Kidney Disorders
Dapagliflozin Dapagliflozin With Metformin Endocrine System, Blood Glucose Lowering Drugs, Biguanides
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Dapagliflozin Dapagliflozin With Metformin Endocrine System, Blood Glucose Lowering Drugs, Sodium Glucose Co-Transporter 2 Inhibitors
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Saxagliptin Saxagliptin With Dapagliflozin Endocrine System, Blood Glucose Lowering Drugs, Dipeptidylpeptidase-4 Inhibitors (Gliptins)
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Saxagliptin Saxagliptin With Dapagliflozin Endocrine System, Blood Glucose Lowering Drugs, Sodium Glucose Co-Transporter 2 Inhibitors
Diabetes Mellitus And Hypoglycaemia, Diabetes Mellitus
Selecting a button in the local column will search the local formulary again for the word on the button. Where the button is in outline no local match at drug name level was found.
Links found
NICE TA288: Dapagliflozin in combination therapy for treating type 2 diabetes
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
NICE TA390: Canagliflozin, dapagliflozin and empagliflozin as monotherapies for treating type 2 diabetes
NICE TA679: Dapagliflozin for treating chronic heart failure with reduced ejection fraction
NICE TA775: Dapagliflozin for chronic kidney disease
NICE TA902: Dapagliflozin for treating chronic heart failure with preserved or mildly reduced ejection fraction
Removal of Type 1 indication for dapagliflozin (DSU Dec 2021)